THE global leader in  blood management solutions for our customers

2018 Press Releases

Webcast ImageWebcast
Q2 2019 Haemonetics Corporation Earnings Conference Call (Replay)
11/06/18 at 8:00 a.m. ET
Q2 2019 Haemonetics Corporation Earnings Conference Call
Tuesday, November 6, 2018 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
Nov. 06, 2018Haemonetics 2nd Quarter and 1st Half Fiscal 2019 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., Nov. 6, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its second fiscal 2019 quarter and first fiscal 2019 half ended September 29, 2018 are available on its Investor relations website. The Company is posting the earnings release and, additionally, results tables that will be referenced on its webcast conference call to its Investor Relations website.  ... 
Printer Friendly Version
Oct. 10, 2018Haemonetics Sets Date for Publishing Second Quarter Fiscal 2019 Results: November 6, 2018
BRAINTREE, Mass., Oct. 10, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal 2019 financial results at 6:00 am EST on Tuesday, November 6, 2018. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on November 6, 2018.  The call can be accessed with the following information: U.S. / Canada toll free (877) 848-8880; I... 
Printer Friendly Version
Aug. 30, 2018Haemonetics to Present at Morgan Stanley's Global Healthcare Conference
BRAINTREE, Mass., Aug. 30, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that Chris Simon, President and CEO, will present at Morgan Stanley's Global Healthcare Conference in New York on Thursday, September 13, 2018 at 11:10am Eastern time. The public may access Mr. Simon's presentation live via webcast and subsequent replay at: https://cc.talkpoint.com/morg007/091218a_as/?entity=117_5KF5F3F. ABOUT HAEMONETICS Haemonetics (NYSE: HA... 
Printer Friendly Version
Aug. 07, 2018Haemonetics Appoints Josep Lluis Llorens As Senior Vice President, Global Manufacturing And Supply Chain
BRAINTREE, Mass., Aug. 7, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today announced the appointment of Josep Lluis Llorens as Senior Vice President, Global Manufacturing and Supply Chain, effective August 20, 2018. He will report to Haemonetics' Chief Executive Officer Chris Simon. Llorens will focus on meaningfully expanding capacity, upscaling strategic sourcing and driving greater throughput, as well as network and SKU rationalization, produ... 
Printer Friendly Version
Aug. 07, 2018Haemonetics 1st Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., Aug. 7, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its first fiscal quarter ended June 30, 2018 are available on its Investor relations website. The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.  Direct link to Earnings Release 1Q19: http://phx... 
Printer Friendly Version
Jul. 19, 2018Haemonetics Sets Date for Publishing First Quarter Fiscal 2019 Results: August 7, 2018
BRAINTREE, Mass., July 19, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish first quarter fiscal 2019 financial results at 6:00 am EST on Tuesday, August 7, 2018. The Company will hold a webcast conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on August 7, 2018.  Webcast Link: https://edge.media-server.com/m6/p/bcyyy75d.   Webcast replay will be availab... 
Printer Friendly Version
Jun. 18, 2018Haemonetics Completes Debt Refinancing With Five-Year Senior Unsecured Credit Facilities
BRAINTREE, Mass., June 18, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company has entered into a new $700 million credit agreement with its lenders, comprised of a $350 million senior unsecured term loan A and a $350 million senior unsecured revolving credit facility, both due 2023. The Company has used initial proceeds from the new credit agreement to repay its $254 million senior unsecured term loan A due June 2019. Chris Si... 
Printer Friendly Version
May. 08, 2018Haemonetics Appoints Said Bolorforosh Executive Vice President, Chief Technology Officer
BRAINTREE, Mass., May 8, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today appointed Said Bolorforosh, Ph.D., Executive Vice President and Chief Technology Officer, effective May 21, 2018. He will report to Chris Simon, Haemonetics' Chief Executive Officer. In this newly-created role, Bolorforosh will lead the company's innovation agenda and oversee research, development and medical and clinical affairs. He will also be responsible for developing... 
Printer Friendly Version
May. 08, 2018Haemonetics 4th Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., May 8, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year ended March 31, 2018 are available on its Investor relations website. The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.  Direct link to Earnings Release 4Q and FY1... 
Printer Friendly Version
Apr. 10, 2018Haemonetics Sets Date for Publishing Fourth Quarter Fiscal 2018 Results: May 8, 2018
BRAINTREE, Mass., April 10, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish fourth quarter fiscal 2018 financial results at 6:00 am EST on Tuesday, May 8, 2018. The Company will hold a webcast conference call with investors and analysts to discuss results and answer questions at 8:00 am EST on May 8, 2018.  Webcast Link: https://edge.media-server.com/m6/p/wcre57f8https://edge.media-server.com/m6/p/qyrbnno... 
Printer Friendly Version
Mar. 28, 2018Haemonetics Announces Regulatory Clearances of NexSys PCS™ Enhanced Software with YES™ Technology
Embedded Software Adds Key Capability to NexSys PCS Platform BRAINTREE, Mass., March 28, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for enhancement of its NexSys PCS™ embedded software. This capability activates the YES™ technology, a yield enhancing solution enabling increases in plasma yield per collection.   This 510(k) cleared by FDA includes the following in... 
Printer Friendly Version
Feb. 06, 2018Haemonetics 3rd Quarter Fiscal 2018 Earnings Release Available on Investor Relations Website
Financial release accessible online BRAINTREE, Mass., Feb. 6, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that third quarter and year-to-date fiscal 2018 financial results are available on its Investor relations website. The Company is posting this press release and, additionally, results tables that will be referenced on its webcast to its Investor Relations website.  Direct link to Earnings Release 3Q and YTD FY18: http:... 
Printer Friendly Version
Jan. 25, 2018Ellen M. Zane Rejoins Haemonetics Board of Directors
BRAINTREE, Mass., Jan. 25, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced the election of Ellen M. Zane to its Board of Directors. Zane is a nationally renowned health care leader with more than 30 years of experience in hospitals and health care systems. Zane led the turnaround of Tufts Medical Center and Floating Hospital for Children in Boston, where she retired as President and Chief Executive Officer in 2011 and currently serves as Vi... 
Printer Friendly Version